YS BIOPHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9779 USD | +2.93% |
|
+0.81% | +91.37% |
| 19/04 | YS Biopharma Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023 | CI |
| 18/04 | YS Biopharma Receives Clinical Trial Approval for Potential Hepatitis B Treatment | MT |
Chart calendar YS Biopharma Co., Ltd.
c2ca0d872146ace9092.EmQYW37b8bS0kwWSr8cmxxLuxAb8XmnzCYJwVY4ZFcM.WD5iNxGdt9j2vlr87IZk8liijV60KgqeP_QiHvd2Iax5UW4zCOuA3-OrXA~36b888d54627d3ea62d5b010cef75455
Upcoming events on YS Biopharma Co., Ltd.
Past events on YS Biopharma Co., Ltd.
| 19/04/2024 05:30 pm | Q3 2024 Earnings Call |
| 19/04/2024 04:30 pm | Q3 2024 Earnings Release |
| 22/02/2024 06:30 am | Extraordinary Shareholders Meeting |
| 16/02/2024 10:30 pm | Extraordinary Shareholders Meeting |
| 23/01/2024 03:30 am | Q2 2024 Earnings Release |
| 28/12/2023 06:30 am | Extraordinary Shareholders Meeting |
| 05/09/2023 | Citi Biopharma Conference |
| 16/08/2023 | Q1 2024 Earnings Call |
| 16/08/2023 02:30 am | Q1 2024 Earnings Release |
| 27/07/2023 | Q4 2023 Earnings Call |
| 27/07/2023 02:30 am | Q4 2023 Earnings Release |
| 23/05/2023 | Virtual Benchmark Healthcare House Call Conference - One on One |
| 18/04/2023 04:30 pm | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | March | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 596 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | -352 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -299 |
|
Net income Million CNY | Released Forecast Spread | -283 | -297 |
|
EPS CNY | Released Forecast Spread | -1,56 | -3,19 |
| Announcement Date | 26/07/23 | - |
Quarterly results
| Fiscal Period | March | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 176 | 96,8 145 -33.35% | 165 143 15.57% | 158 | 176 | 185 | 200 | 230 |
|
EBIT Million CNY | Released Forecast Spread | -113 -70,8 -59.98% | -81,7 -61,2 -33.46% | -49,4 | |||||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -105 -77,3 -36.18% | -85,2 -67,7 -25.88% | -55,9 | |||||
|
Net income Million CNY | Released Forecast Spread | -105 -77,3 -35.88% | -77,8 -67,1 -15.92% | -55,3 | |||||
|
EPS CNY | Released Forecast Spread | -1,13 -0,82 -37.8% | -0,83 -0,72 -15.28% | -0,59 | |||||
| Announcement Date | 16/08/23 | 22/01/24 | 19/04/24 | - | - | - | - | - |
| 11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
| 26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for YS Biopharma Co., Ltd.
| 14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 13/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:35 am | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- YS Stock
- Calendar YS Biopharma Co., Ltd.
